Global CRO SYNthesis med chem, a provider of synthetic and medicinal chemistry services, has opened a new facility at the Babraham Research Campus in Cambridge, U.K.

SYNthesis operates a business model combining medicinal chemistry experience located at the company's labs in Melbourne, Australia, and now in Cambridge, with flexible, high-quality, cost-effective synthetic chemistry experience provided by the company's synthetic chemists based in Shanghai, China.

The Cambridge facility has enabled SYNthesis to add U.K.-based medicinal chemistry experience to the organization and  provide European customers with local project management for all synthetic and medicinal chemistry projects.